NASDAQ
CLSN

Celsion Corporation

Prices are adjusted according to historical splits.

Celsion Corporation Stock Price

Vitals

Today's Low:
$
Today's High:
$
Open Price:
$
52W Low:
$0.6865
52W High:
$6.5
Prev. Close:
$
Volume:

Company Statistics

Market Cap.:
$0.024 billion
Book Value:
0.729
Revenue TTM:
$0.001 billion
Operating Margin TTM:
-3933.63%
Gross Profit TTM:
$0.000 billion
Gross Profit TTM:
$0.000 billion
Profit Margin:
0%
Return on Assets TTM:
-27.22%
Return on Equity TTM:
-88.19%

Company Profile

Celsion Corporation had its IPO on 1999-03-01 under the ticker symbol CLSN.

The company operates in the sector and industry. Celsion Corporation has a staff strength of 29 employees.

Stock update

Shares of Celsion Corporation opened at $0 at the start of the last trading session i.e. .

The stocks traded within a range of $0 - $0, and closed at $0.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Celsion Corporation have increased by 0%.

Celsion Corporation's Key Ratios

Celsion Corporation has a market cap of $0.024 billion, indicating a price to book ratio of 1.0059 and a price to sales ratio of 37.2164.

In the last 12-months Celsion Corporation’s revenue was $0.001 billion with a gross profit of $0.000 billion and an EBITDA of $-0.019 billion. The EBITDA ratio measures Celsion Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Celsion Corporation’s operating margin was -3933.63% while its return on assets stood at -27.22% with a return of equity of -88.19%.

In Q2, Celsion Corporation’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Celsion Corporation’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.733 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Celsion Corporation’s profitability.

Celsion Corporation stock is trading at a EV to sales ratio of 20.4884 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 37.2164.

Celsion Corporation stock pays annual dividends of $None per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Celsion Corporation ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Celsion Corporation ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Celsion Corporation’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Celsion Corporation's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Celsion Corporation paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0
52-Week High
$6.5
52-Week Low
$0.6865
Analyst Target Price
$6

Celsion Corporation stock is currently trading at $0 per share. It touched a 52-week high of $6.5 and a 52-week low of $6.5. Analysts tracking the stock have a 12-month average target price of $6.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 1.33 indicating a short percent outstanding of 3%.

Around 128.8% of the company’s stock are held by insiders while 1561.3% are held by institutions.

Frequently Asked Questions About Celsion Corporation

The stock symbol (also called stock or share ticker) of Celsion Corporation is CLSN

The IPO of Celsion Corporation took place on 1999-03-01

Similar Industry Stocks ()

Last Price
Chg
Chg%
8×8 Inc (EGHT)
$4.03
-0.17
-4.05%
$22.6
-0.34
-1.48%
$14.11
-0.49
-3.36%
$35.1
-1.24
-3.41%
$4.8
-0.36
-6.98%
$2.67
-0.06
-2.2%
$11.84
-0.67
-5.36%
$3.61
-0.05
-1.37%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.

Address

997 Lenox Drive, Lawrenceville, NJ, United States, 08648